BCL2 and cancer: This raises the question whether cancer cells, in particular Bcl-2-dependent malignancies, displayed altered Ca2+-signaling properties that turned these cells into vulnerable targets toward peptides disrupting Bcl-2-mediated suppression of apoptotic IP3R activity.